Gene · 5172
Papers3,149
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,149
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| G-quadruplex stabilization induces DNA breaks in pericentromeric repetitive DNA sequences in B lymphocytes. | Proc Natl Acad Sci U S A | 2025 | 40833407 | PubTator, text mining | PubMed |
| Structural basis for substrate recognition mechanism of human SLC26A7. | Nat Commun | 2025 | 40817112 | PubTator, text mining | PubMed |
| Prussian blue analog-derived Fe-Mn oxides for the enhanced activation of persulfate in sulfadiazine degradation: radical generation mechanism and electron transfer. | Environ Res | 2025 | 40812708 | PubTator, text mining | PubMed |
| Novel SLC26A4 variant in Pendred syndrome with non-classical inheritance: a case report. | Eur Arch Otorhinolaryngol | 2025 | 40779065 | PubTator, text mining | PubMed |
| Bilateral Enlarged Vestibular Aqueduct: Auditory, Genetic and Radiological Characterization, and Benefits of Cochlear Implants. | Otolaryngol Head Neck Surg | 2025 | 40760936 | PubTator, text mining | PubMed |
| Gene Expression Analysis of Papillary Thyroid Carcinoma With Lymph Node Metastasis and Radioiodine Refractivity. | Cureus | 2025 | 40746809 | PubTator, text mining | PubMed |
| [Prediction of hearing change in children with enlarged vestibular aqueduct with different genotypes by linear mixed-effects model]. | Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2025 | 40744881 | PubTator, text mining | PubMed |
| Computational prediction of the pathogenic variants of arachidonate 5-lipoxygenase activating protein using Molecular Dynamics simulation. | PLoS One | 2025 | 40737279 | PubTator, text mining | PubMed |
| Perspectives of user groups in the co-creation of a targeted dental care service intervention for older adults receiving home healthcare: an explorative study. | BMC Health Serv Res | 2025 | 40734178 | PubTator, text mining | PubMed |
| Tumor extracellular matrix enhances invasive gene expression of breast cancer cells in 3D patient-derived scaffolds. | Sci Rep | 2025 | 40730611 | PubTator, text mining | PubMed |
| External quality assessment of genetic testing for hereditary hearing loss in Shanghai and other regions. | Pract Lab Med | 2025 | 40688347 | PubTator, text mining | PubMed |
| Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments. | Nucleic Acids Res | 2025 | 40682824 | PubTator, text mining | PubMed |
| Medium-Voltage AC Cable Joints: A Review of Testing Methods, Standards, and Emerging Trends. | Sensors (Basel) | 2025 | 40648101 | PubTator, text mining | PubMed |
| Clinicopathological and molecular characteristics of papillary thyroid carcinoma with BRAF V600E and TERT promoter co-mutations. | Pathol Res Pract | 2025 | 40645017 | PubTator, text mining | PubMed |
| Persulfate Activation by Encapsulated Sulfidated Nanoscale Zerovalent Iron for 2,4-Dichlorophenol Removal. | Langmuir | 2025 | 40629723 | PubTator, text mining | PubMed |
| Comparison of clinical performance of MeltPro hearing loss assay and targeted next generation sequencing assay for genetic screening of hearing loss. | Sci Rep | 2025 | 40595116 | PubTator, text mining | PubMed |
| [Analysis and clinical characteristics of SLC26A4 gene mutations in 72 cases of large vestibular aqueduct syndrome]. | Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2025 | 40555484 | PubTator, text mining | PubMed |
| Low Efficiency of Homology-Independent Targeted Integration for CRISPR/Cas9 Correction in the Vicinity of the SLC26A4 c.919-2A>G Variant. | Int J Mol Sci | 2025 | 40507794 | PubTator, text mining | PubMed |
| Clinical and Genetic Characteristics of Adult Nonautoimmune Hypothyroidism: A Single-institution Study. | J Clin Endocrinol Metab | 2025 | 40501123 | PubTator, text mining | PubMed |
| Trends and mechanisms of Alzheimer's disease and hearing impairment: A 20-year perspective. | Ageing Res Rev | 2025 | 40499729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5172/papers?page=7